Loading...
Please wait, while we are loading the content...
Similar Documents
Effects of Statins on High-Density Lipoproteins: A Potential Contribution to Cardiovascular Benefit
| Content Provider | Paperity |
|---|---|
| Author | Jones, Peter Mctaggart, Fergus |
| Abstract | Purpose The objective was to systematically review clinical trial data on the effects of statins on high-density lipoproteins (HDL) and to examine the possibility that this provides cardiovascular benefits in addition to those derived from reductions in low-density lipoproteins (LDL). Methods The PubMed database was searched for publications describing clinical trials of atorvastatin, pravastatin, rosuvastatin, and simvastatin. On the basis of predefined criteria, 103 were selected for review. Results Compared with placebo, statins raise HDL, measured as HDL-cholesterol (HDL-C) and apolipoprotein A-I (apo A-I); these elevations are maintained in the long-term. In hypercholesterolemia, HDL-C is raised by approximately 4% to 10%. The percentage changes are greater in patients with low baseline levels, including those with the common combination of high triglycerides (TG) and low HDL-C. These effects do not appear to be dose-related although there is evidence that, with the exception of atorvastatin, the changes in HDL-C are proportional to reductions in apo B-containing lipoproteins. The most likely explanation is a reduced rate of cholesteryl ester transfer protein (CETP)-mediated flow of cholesterol from HDL. There is some evidence that the statin effects on HDL reduce progression of atherosclerosis and risk of cardiovascular disease independently of reductions in LDL. Conclusion Statins cause modest increases in HDL-C and apo A-I probably mediated by reductions in CETP activity. It is plausible that such changes independently contribute to the cardiovascular benefits of the statin class but more studies are needed to further explore this possibility. |
| Starting Page | 321 |
| File Format | HTM / HTML |
| ISSN | 09203206 |
| DOI | 10.1007/s10557-008-6113-z |
| Issue Number | 4 |
| Journal | Cardiovascular Drugs and Therapy |
| Volume Number | 22 |
| e-ISSN | 15737241 |
| Language | English |
| Publisher | Springer US |
| Publisher Date | 2008-08-01 |
| Access Restriction | Open |
| Subject Keyword | Cardiovascular disease Statin High-density lipoprotein Lipid-lowering therapy Cholesterol Atherosclerosis |
| Content Type | Text |
| Resource Type | Article |
| Subject | Pharmacology Pharmacology (medical) Cardiology and Cardiovascular Medicine |
